Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system.
FNA
gene fusions
molecular cytopathology
molecular testing
salivary glands
Journal
Cytopathology : official journal of the British Society for Clinical Cytology
ISSN: 1365-2303
Titre abrégé: Cytopathology
Pays: England
ID NLM: 9010345
Informations de publication
Date de publication:
02 Feb 2024
02 Feb 2024
Historique:
revised:
17
01
2024
received:
20
06
2023
accepted:
18
01
2024
medline:
3
2
2024
pubmed:
3
2
2024
entrez:
3
2
2024
Statut:
aheadofprint
Résumé
Recently, significant advances in the molecular characterization of salivary gland neoplasms have facilitated the classification and diagnosis of specific diagnostic entities. In the highly challenging diagnostic scenario of salivary malignancies, molecular testing is increasingly being adopted in routine practice to refine the cytological diagnosis of salivary lesions. Here, we reviewed the most recent evidence in the field of salivary glands molecular cytopathology.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Cytopathology published by John Wiley & Sons Ltd.
Références
Layfield LJ, Gopez E, Hirschowitz S. Cost efficiency analysis for fine-needle aspiration in the workup of parotid and submandibular gland nodules. Diagn. Cytopathol. 2006;34(11):734-738.
Rossi ED, Faquin WC, Baloch Z, et al. The Milan system for reporting salivary gland cytopathology: analysis and suggestions of initial survey. Cancer Cytopathol. 2017;125(10):757-766.
Song SJ, Shafique K, Wong LQ, LiVolsi VA, Montone KT, Baloch Z. The utility of the Milan system as a risk stratification tool for salivary gland fine needle aspiration cytology specimens. Cytopathology. 2019;30(1):91-98.
Viswanathan K, Sung S, Scognamiglio T, Yang GCH, Siddiqui MT, Rao RA. The role of the Milan system for reporting salivary gland cytopathology: a 5-year institutional experience. Cancer Cytopathol. 2018;126(8):541-551.
Barbarite E, Puram SV, Derakhshan A, Rossi ED, Faquin WC, Varvares MA. A call for universal acceptance of the Milan system for reporting salivary gland cytopathology. Laryngoscope. 2020;130(1):80-85.
Skálová A, Hyrcza MD, Leivo I. Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands. Head Neck Pathol. 2022;16(1):40-53.
Allison DB, Smith AP, An D, et al. Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan system for reporting salivary gland cytopathology: An international, multi-institutional study. Cancer Cytopathol. 2021;129(1):43-52.
Colella G, Cannavale R, Flamminio F, Foschini MP. Fine-needle aspiration cytology of salivary gland lesions: a systematic review. J Oral Maxillofac Surg off J Am Assoc Oral Maxillofac Surg. 2010;68(9):2146-2153.
Salehi S, Maleki Z. Diagnostic challenges and problem cases in salivary gland cytology: a 20-year experience. Cancer Cytopathol. 2018;126(2):101-111.
Torous VF, Faquin WC. The Milan system classification of Warthin tumor: a large institutional study of 124 cases highlighting cytologic features that limit definitive interpretation. Cancer Cytopathol. 2022;130(9):714-725.
Seifert G, Bull HG, Donath K. Histologic subclassification of the cystadenolymphoma of the parotid gland. Analysis of 275 cases. Virchows Arch. A Pathol. Anat. Histol. 1980;388(1):13-38.
Agaimy A, Mantsopoulos K, Iro H, Stoehr R. KRAS codon 12 mutations characterize a subset of de novo proliferating “metaplastic” Warthin tumors. Virchows Arch. 2023;482:839-848.
White VA, Hyrcza MD, Lennerz JK, et al. Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? Mod Pathol J United States Can Acad Pathol Inc. 2022;35(10):1484-1493.
Schneider T, Strehl A, Linz C, et al. Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas. Clin. Oral Investig. 2016;20(3):541-551.
Liu H, Ljungren C, Lin F, Zarka MA, Chen L. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan system for reporting salivary gland cytopathology. Cancer Cytopathol. 2018;126(7):490-497.
Schmitt AC, Griffith CC, Cohen C, Siddiqui MT. LEF-1: diagnostic utility in distinguishing basaloid neoplasms of the salivary gland. Diagn. Cytopathol. 2017;45(12):1078-1083.
Rooper LM, McCuiston AM, Westra WH, Bishop JA. SOX10 Immunoexpression in basaloid squamous cell carcinomas: a diagnostic pitfall for ruling out salivary differentiation. Head Neck Pathol. 2019;13(4):543-547.
Hsieh M-S, Lee Y-H, Chang Y-L. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma. Hum. Pathol. 2016;56:134-142.
Jo VY, Sholl LM, Krane JF. Distinctive patterns of CTNNB1 (β-catenin) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am. J. Surg. Pathol. 2016;40(8):1143-1150.
Emanuel P, Wang B, Wu M, Burstein DE. p63 immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol J United States Can Acad Pathol Inc. 2005;18(5):645-650.
Moon A, Cohen C, Siddiqui MT. MYB expression: potential role in separating adenoid cystic carcinoma (ACC) from pleomorphic adenoma (PA). Diagn. Cytopathol. 2016;44(10):799-804.
Parwani AV, Lujan G, Ali SZ. Myoepithelial carcinoma arising in a pleomorphic adenoma of the parotid gland: report of a case with cytopathologic findings. Acta Cytol. 2006;50(1):93-96.
Taweevisit M, Thorner PS. Pleomorphic adenoma with bizarre myoepithelial cells: a diagnostic challenge on cytologic smear. Diagn. Cytopathol. 2019;47(12):1283-1286.
Viguer JM, Vicandi B, Jiménez-Heffernan JA, López-Ferrer P, Limeres MA. Fine needle aspiration cytology of pleomorphic adenoma. An analysis of 212 cases. Acta Cytol. 1997;41(3):786-794.
Stenman G, Fehr A, Skálová A, et al. Chromosome translocations, gene fusions, and their molecular consequences in pleomorphic salivary gland adenomas. Biomedicines. 2022;10(8):1970.
Baněčková M, Uro-Coste E, Ptáková N, et al. What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases. Hum. Pathol. 2020;103:52-62.
Skálová A, Agaimy A, Vanecek T, et al. Molecular profiling of clear cell Myoepithelial carcinoma of salivary glands with EWSR1 rearrangement identifies frequent PLAG1 gene fusions but No EWSR1 fusion transcripts. Am. J. Surg. Pathol. 2021;45(1):1-13.
Dalin MG, Katabi N, Persson M, et al. Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions. Nat. Commun. 2017;8(1):1197.
Rupp NJ, Höller S, Brada M, et al. Expanding the clinicopathological spectrum of TGFBR3-PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high-grade transformation. Genes Chromosomes Cancer. 2022;61(2):94-104.
Chiosea SI, Thompson LDR, Weinreb I, et al. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer. 2016;122(20):3136-3144.
Kawahara A, Harada H, Akiba J, Yokoyama T, Kage M. Fine-needle aspiration cytology of basal cell adenoma of the parotid gland: characteristic cytological features and diagnostic pitfalls. Diagn. Cytopathol. 2007;35(2):85-90.
Jurczyk M, Peevey JF, Vande Haar MA, Lin X. Pitfalls of fine-needle aspiration cytology of parotid membranous basal cell adenoma-a review of pitfalls in FNA cytology of salivary gland neoplasms with basaloid cell features. Diagn. Cytopathol. 2015;43(5):432-437.
Robinson RA. Basal Cell Adenoma and Basal Cell Adenocarcinoma. Surg. Pathol. Clin. 2021;14(1):25-42.
Singh J, Chandra A, Srilatha T, Jain T, Raja D, Agrawal R. Oncocytoma of the parotid gland: a rare benign tumour. J. Oral Maxillofacial Pathol. 2023;27:S41-S44.
De Luise M, Girolimetti G, Okere B, Porcelli AM, Kurelac I, Gasparre G. Molecular and metabolic features of oncocytomas: seeking the blueprints of indolent cancers. Biochim. Biophys. Acta Bioenerg. 2017;1858(8):591-601.
Bundele M, Weinreb I, Xu B, et al. Mucoacinar carcinoma: a rare variant of Mucoepidermoid carcinoma. Am. J. Surg. Pathol. 2021;45(8):1028-1037.
Skálová A, Agaimy A, Stanowska O, et al. Molecular profiling of salivary Oncocytic Mucoepidermoid carcinomas helps to resolve differential diagnostic dilemma with Low-grade Oncocytic lesions. Am. J. Surg. Pathol. 2020;44(12):1612-1622.
Freiberger SN, Brada M, Fritz C, et al. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets. Neoplasia. 2021;23(5):473-487.
Vasudevan G, Bishnu A, Singh BMK, Singh VK. Mucoepidermoid carcinoma of salivary gland: limitations and pitfalls on FNA. J. Clin. Diagn. Res. 2017;11(5):ER04-ER06.
Basak K, Mericoz CA, Firat P. Warthin-like Mucoepidermoid carcinoma: a morphological Spectrum - a report of 3 cases with histological and cytological findings and review of the literature. Acta Cytologica. 2022;66:244-252.
Wade TV, Livolsi VA, Montone KT, Baloch ZW. A cytohistologic correlation of mucoepidermoid carcinoma: emphasizing the rare oncocytic variant. Pathol. Res. Int. 2011;2011:135796.
Bishop JA, Thompson LDR, Siegele B, et al. Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2- rearranged salivary gland tumours. Histopathology. 2023;82(2):305-313.
Russell-Goldman E, Hanna J. MAML2 gene rearrangement occurs in nearly all Hidradenomas: a reappraisal in a series of 20 cases. Am. J. Dermatopathol. 2022;44(11):806-811.
Saeed OA, Whaley RD, Segura S, Wu HH, Cramer H. The cytology of salivary gland neoplasms with globules of extracellular matrix: case-based review of adenoid cystic carcinoma and its potential mimics. Diagn. Cytopathol. 2021;49(6):E195-E202.
Tabatabai ZL, Auger M, Kurtycz DFI, et al. Performance characteristics of adenoid cystic carcinoma of the salivary glands in fine-needle aspirates: results from the College of American Pathologists Nongynecologic Cytology Program. Arch. Pathol. Lab Med. 2015;139(12):1525-1530.
Persson M, Andersson MK, Mitani Y, et al. Rearrangements, expression, and clinical significance of MYB and MYBL1 in adenoid cystic carcinoma: a multi-institutional study. Cancers (Basel). 2022;14(15):3691.
Mathew EP, Todorovic E, Truong T, et al. Metatypical adenoid cystic carcinoma: a variant showing prominent squamous differentiation with a predilection for the Sinonasal tract and Skull Base. Am. J. Surg. Pathol. 2022;46(6):816-822.
Rooper LM, Lombardo KA, Oliai BR, Ha PK, Bishop JA. MYB RNA in situ hybridization facilitates sensitive and specific diagnosis of adenoid cystic carcinoma regardless of translocation status. Am. J. Surg. Pathol. 2021;45(4):488-497.
Weinreb I, Rooper LM, Dickson BC, et al. Adenoid cystic carcinoma with striking tubular Hypereosinophilia: a unique pattern associated with nonparotid location and both canonical and novel EWSR1::MYB and FUS::MYB fusions. Am. J. Surg. Pathol. 2023;47(4):497-503.
Ferrarotto R, Mitani Y, Diao L, et al. Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2017;35(3):352-360.
Wakely PEJ, Lott-Limbach AA. Cytopathology of acinic cell carcinoma: a study of 50 cases, including 9 with high-grade transformation. Cancer Cytopathol. 2021;129(12):973-983.
Hughes JH, Volk EE, Wilbur DC. Pitfalls in salivary gland fine-needle aspiration cytology: lessons from the College of American Pathologists Interlaboratory Comparison Program in nongynecologic cytology. Arch. Pathol. Lab Med. 2005;129(1):26-31.
Daneshbod Y, Daneshbod K, Khademi B. Diagnostic difficulties in the interpretation of fine needle aspirate samples in salivary lesions: diagnostic pitfalls revisited. Acta Cytol. 2009;53(1):53-70.
Nagel H, Laskawi R, Büter JJ, Schröder M, Chilla R, Droese M. Cytologic diagnosis of acinic-cell carcinoma of salivary glands. Diagn. Cytopathol. 1997;16(5):402-412.
Klijanienko J, Vielh P. Fine-needle sample of salivary gland lesions. V: cytology of 22 cases of acinic cell carcinoma with histologic correlation. Diagn. Cytopathol. 1997;17(5):347-352.
Michal M, Skálová A, Simpson RH, Leivo I, Ryska A, Stárek I. Well-differentiated acinic cell carcinoma of salivary glands associated with lymphoid stroma. Hum. Pathol. 1997;28(5):595-600.
Mir F, Rohra P, Aakash N, et al. Acinic cell carcinoma of the salivary gland associated with lymphoid-rich stroma. A diagnostic dilemma on cytology: study of two cases. Diagn. Cytopathol. 2021;49(2):E55-E59.
Schmitt AC, Cohen C, Siddiqui MT. Expression of SOX10 in salivary gland Oncocytic neoplasms: a review and a comparative analysis with other Immunohistochemical markers. Acta Cytol. 2015;59(5):384-390.
Chênevert J, Duvvuri U, Chiosea S, et al. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol an off J United States Can Acad Pathol Inc. 2012;25(7):919-929.
Andreasen S, Varma S, Barasch N, et al. The HTN3-MSANTD3 fusion gene defines a subset of Acinic cell carcinoma of the salivary gland. Am. J. Surg. Pathol. 2019;43(4):489-496.
Haller F, Bieg M, Will R, et al. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat. Commun. 2019;10(1):368.
Viswanathan K, Beg S, He B, et al. NR4A3 immunostain is a highly sensitive and specific marker for Acinic cell carcinoma in Cytologic and surgical specimens. Am. J. Clin. Pathol. 2022;157(1):98-108.
Haller F, Skálová A, Ihrler S, et al. Nuclear NR4A3 immunostaining is a specific and sensitive novel marker for Acinic cell carcinoma of the salivary glands. Am. J. Surg. Pathol. 2019;43(9):1264-1272.
Meiklejohn K, Hrones M, Wang M, et al. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: role of NOR-1 (NR4A3) immunohistochemistry. Cytopathology. 2023;34(3):219-224.
Bishop JA, Yonescu R, Batista DAS, Westra WH, Ali SZ. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol. 2013;121(5):228-233.
Oza N, Sanghvi K, Shet T, et al. Mammary analogue secretory carcinoma of parotid: is preoperative cytological diagnosis possible? Diagn. Cytopathol. 2016;44(6):519-525.
Hua Y, Leng B, Youens KE, Liu L. An underappreciated Cytomorphological feature of secretory carcinoma of salivary gland on fine needle aspiration biopsy: case report with literature review. Head Neck Pathol. 2022;16(2):567-572.
Sethi R, Kozin E, Remenschneider A, et al. Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy. Laryngoscope. 2014;124(1):188-195.
Ito H, Ishida M, Ebisu Y, et al. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland. Diagn. Cytopathol. 2021;49(8):E329-E335.
Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am. J. Surg. Pathol. 2010;34(5):599-608.
Ye Q, Chen H, Han C, et al. Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma. J. Clin. Pathol. 2023;jcp-2023-208989. doi:10.1136/jcp-2023-208989. Epub ahead of print.
Skálová A, Banečkova M, Thompson LDR, et al. Expanding the molecular Spectrum of secretory carcinoma of salivary glands with a novel VIM-RET fusion. Am. J. Surg. Pathol. 2020;44(10):1295-1307.
Skalova A, Vanecek T, Martinek P, et al. Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am. J. Surg. Pathol. 2018;42(2):234-246.
Wakely PEJ, Lott-Limbach AA. Classic polymorphous adenocarcinoma: fine needle aspiration cytopathology of eight cases. Cytopathology. 2021;32(6):789-794.
Weinreb I, Zhang L, Tirunagari LMS, et al. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin. Genes Chromosomes Cancer. 2014;53(10):845-856.
Katabi N, Xu B. Polymorphous adenocarcinoma. Surg. Pathol. Clin. 2021;14(1):127-136.
Xu B, Barbieri AL, Bishop JA, et al. Histologic classification and molecular signature of polymorphous adenocarcinoma (PAC) and cribriform adenocarcinoma of salivary gland (CASG): An international Interobserver study. Am. J. Surg. Pathol. 2020;44(4):545-552.
Donath K, Seifert G, Schmitz R. Diagnosis and ultrastructure of the tubular carcinoma of salivary gland ducts. Epithelial-myoepithelial carcinoma of the intercalated ducts. Virchows Arch. A Pathol. Pathol. Anat. 1972;356(1):16-31.
Miliauskas JR, Orell SR. Fine-needle aspiration cytological findings in five cases of epithelial-myoepithelial carcinoma of salivary glands. Diagn. Cytopathol. 2003;28(3):163-167.
Molnar SL, Zarka MA, De Las Casas LE. Going beyond “basaloid neoplasm”: fine needle aspiration cytology of epithelial-myoepithelial carcinoma of the parotid gland. Diagn. Cytopathol. 2016;44(5):422-425.
Hang J-F, Alruwaii F, Zeng B-R, Lai C-R, Wu HH. Subtyping salivary gland neoplasm of uncertain malignant potential based on cell type demonstrates differential risk of malignancy. Cancer Cytopathol. 2018;126(11):924-933.
Urano M, Nakaguro M, Yamamoto Y, et al. Diagnostic significance of HRAS mutations in epithelial-Myoepithelial carcinomas exhibiting a broad histopathologic Spectrum. Am. J. Surg. Pathol. 2019;43(7):984-994.
Mueller SA, Gauthier M-EA, Blackburn J, et al. Molecular patterns in salivary duct carcinoma identify prognostic subgroups. Mod Pathol an off J United States Can Acad Pathol Inc. 2020;33(10):1896-1909.
Wakely PE. Salivary duct carcinoma: a report of 70 FNA cases and review of the literature. Cancer Cytopathol. 2022;130(8):595-608.
Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer. 1996;77(2):223-230.
Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M. Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer. 2001;93(5):344-350.
Matloob A, Beute JE, Gidumal S, et al. Oncocytoid variant of high-grade salivary duct carcinoma: a potential diagnostic pitfall. A report on two patients. Head Neck Pathol. 2022;16(3):947-955.
Cavalieri S, Nuzzolese I, Ottini A, et al. HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients. Front. Oncol. 2022;12:1096068.
McAfee JL, Hoda RS, Hoyle C, et al. ERBB2 amplification and HER2 expression in salivary duct carcinoma: evaluation of scoring guidelines and potential for expanded anti-HER2 therapy. Mod Pathol an off J United States Can Acad Pathol Inc. 2023;36(10):100273.
Skalova A, Leivo I, Hellquist H, et al. High-grade transformation/dedifferentiation in salivary gland carcinomas: occurrence across subtypes and clinical significance. Adv. Anat. Pathol. 2021;28(3):107-118.
Palicelli A. What do we know about the cytological features of pure intraductal carcinomas of the salivary glands? Cytopathology. 2020;31(3):185-192.
Viswanathan K, Sadow PM, Maleki Z, et al. Cytomorphologic features of intraductal salivary gland carcinoma: a multi-institutional study of 13 FNA cases with histologic, molecular, and clinical correlations. Cancer Cytopathol. 2021;129(12):928-946.
Skálová A, Ptáková N, Santana T, et al. NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary Intraductal carcinoma, including invasive and metastatic tumors: is “Intraductal” correct? Am. J. Surg. Pathol. 2019;43(10):1303-1313.
Bishop JA, Nakaguro M, Whaley RD, et al. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations. Histopathology. 2021;79(3):338-346.
Bishop JA, Gagan J, Krane JF, Jo VY. Low-grade apocrine Intraductal carcinoma: expanding the morphologic and molecular Spectrum of an enigmatic salivary gland tumor. Head Neck Pathol. 2020;14(4):869-875.
Lui SK, Tenney T, Mullane PC, Viswanathan K, Lubin DJ. Nondiagnostic salivary gland FNAs are associated with decreased risk of malignancy compared with “all-comer” patients: analysis of the Milan system for reporting salivary gland cytopathology with a focus on Milan I: nondiagnostic. Cancer Cytopathol. 2022;130(10):800-811.
Griffith CC, Pai RK, Schneider F, et al. Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am. J. Clin. Pathol. 2015;143(6):839-853.
Thiryayi SA, Low YX, Shelton D, Narine N, Slater D, Rana DN. A retrospective 3-year study of salivary gland FNAC with categorisation using the Milan reporting system. Cytopathology. 2018;29(4):343-348.
Higuchi K, Urano M, Akiba J, et al. A multi-institutional study of salivary gland cytopathology: application of the Milan system for reporting salivary gland cytopathology in Japan. Cancer Cytopathol. 2022;130(1):30-40.
Poller DN, Kandaswamy P. A simplified economic approach to thyroid FNA cytology and surgical intervention in thyroid nodules. J. Clin. Pathol. 2013;66(7):583-588.
Lee JJL, Tan HM, Chua DYS, Chung JGK, Nga ME. The Milan system for reporting salivary gland cytology: a retrospective analysis of 1384 cases in a tertiary southeast Asian institution. Cancer Cytopathol. 2020;128(5):348-358.
Layfield LJ, Gopez EV. Cystic lesions of the salivary glands: cytologic features in fine-needle aspiration biopsies. Diagn. Cytopathol. 2002;27(4):197-204.
Mohammed Nur M, Murphy M. Adequacy and accuracy of salivary gland fine needle aspiration cytology. Ir. J. Med. Sci. 2016;185(3):711-716.
Sun L, Petrone JS, McNulty SN, et al. Comparison of gene fusion detection methods in salivary gland tumors. Hum. Pathol. 2022;123:1-10.
Hudson JB, Collins BT. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization. Arch. Pathol. Lab Med. 2014;138(3):403-409.
Evrard SM, Meilleroux J, Daniel G, et al. Use of fluorescent in-situ hybridisation in salivary gland cytology: a powerful diagnostic tool. Cytopathology. 2017;28(4):312-320.
Oh J, Yoo TY, Saal TM, et al. Multiplexed single-cell analysis of FNA allows accurate diagnosis of salivary gland tumors. Cancer Cytopathol. 2022;130(8):581-594.
Todorovic E, Dickson BC, Weinreb I. Salivary gland cancer in the era of routine next-generation sequencing. Head Neck Pathol. 2020;14(2):311-320.
Wang H, Fundakowski C, Khurana JS, Jhala N. Fine-needle aspiration biopsy of salivary gland lesions. Arch. Pathol. Lab Med. 2015;139(12):1491-1497.
Pusztaszeri MP, García JJ, Faquin WC. Salivary gland FNA: new markers and new opportunities for improved diagnosis. Cancer Cytopathol. 2016;124(5):307-316.
Bellevicine C, Malapelle U, Vigliar E, Pisapia P, Vita G, Troncone G. How to prepare cytological samples for molecular testing. J. Clin. Pathol. 2017;70(10):819-826.
Weinreb I, Piscuoglio S, Martelotto LG, et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. Nat. Genet. 2014;46(11):1166-1169.